Vicore Pharma: FDA Approval to initiate Phase 3 trial using C21 in Covid
Vicore announced this morning that the FDA has accepted its IND application to initiate its pivotal Covid-19 trial in the US. We give a brief comment on the positive milestone.
FT
Fredrik Thor
Disclosures and disclaimers